Athletigen teams up with CrossFit leader MobilityWOD
HALIFAX – September 17, 2018 – Athletigen Technologies, Inc. has announced the launch of its Optimum Movement and Recovery report, a DNA product that was created in partnership with Dr. Kelly Starrett and his company MobilityWOD.
The report uses 23andMe, AncestryDNA, or Athletigen DNA data, for more than 70 genetic markers to deliver 25 fundamental insights into injury risk, exercise recovery, and sleep hygiene. Customers who have already had their DNA sequenced can now use the Optimum Movement and Recovery report to gain additional knowledge about their bodies. Alternatively, if customers need a DNA kit to start their genetic journey, they can purchase one directly from Athletigen.
“It’s exciting to see people use their DNA to explore the depths of their unique human technology. Working together with Dr. Kelly and Juliet Starrett to deliver a solution that helps people make informed decisions for optimal performance and informed living has been pure joy,” says Athletigen CEO Dr. Jeremy Koenig. “It is an honour to work side by side with people who are experts in their craft and who are driven to help humans perform, feel, and live better. We want to continue to help people make decisions based on their individual bodies. This kind of interdisciplinary collaboration is essential to make this a reality for all humans.”
The Optimum Movement and Recovery report, while non-diagnostic, helps customers understand the impact of DNA on traits such as tendon and ligament injury risk, post-exercise soreness and inflammation, and sleep quality. Understanding our DNA foundation can be empowering, giving every person the ability to take charge of their health. Every person’s DNA is 99.5% the same. By understanding the 0.5% that makes each person unique, as well as the environmental factors that combine with DNA to influence athletic performance and recovery, people can make more informed lifestyle decisions daily.
MobilityWOD was founded in 2005 by Dr. Kelly Starrett and Juliet Starrett with the goal of becoming the ultimate guide to eliminating pain, preventing injury and maximizing athletic performance. MobilityWOD has grown into a leader in the CrossFit industry and has worked with high-profile clients such as the New Zealand All Blacks, UFC fighter Georges St. Pierre, actor Jason Statham, and author Tim Ferriss.
“Genetics and understanding the implication of modern genetics on my person is here to stay. It’s going to be part of the conversation,” said MobilityWOD founder Kelly Starrett. “The problem is that trying to sort through and make sense of this incredible technology is difficult, at best. So we have partnered with our friends at Athletigen to take your DNA data and translate it into actionable steps and real behaviors that can improve your life.”
Athletigen is funded by private equity investors, the Government of Canada through repayable loans from the Atlantic Canada Opportunities Agency, and the province of Nova Scotia through Nova Scotia Business Inc.
—- 30 —-
Click here for a sample version of the Optimum Movement and Recovery DNA report.
Athletigen is a company founded on the same performance principles that are used to help the most elite athletes in the world achieve greatness. We are driven to empower all people to understand their DNA and reach their full potential. Our mission is to help people connect their DNA data to products and services that are specific to their personal needs and are aligned with a healthful life. We achieve this through adhering to the highest scientific standards, a commitment to education, and strategic alignment with partners who embrace our passion for performance. We believe that everyone is Made for More™.
About Athletigen’s Optimum Movement and Recovery Report
The new Optimum Movement and Recovery DNA report from Athletigen and MobilityWOD unlocks the power of raw DNA data files provided to every 23andMe and AncestryDNA customer with over 25 insights into injury risk, exercise recovery, and sleep hygiene. These traits include:
About Dr. Jeremy Koenig
Dr. Jeremy Koenig, Athletigen CEO and Founder, has a background in commercializing genetic information into practical applications. Dr. Koenig was a varsity track-and-field athlete during the completion of his Ph.D. in Biochemistry and Molecular Biology at Dalhousie University in Halifax, Nova Scotia, Canada. Following graduate school, Dr. Koenig pursued postdoctoral training in human microbiome and genetics research at Cornell University. He was a Professor of Nutrigenomics, before moving to the biomedical industry to work on developing and commercializing a genetics-based fertility test. He founded Athletigen in 2014 to accelerate scientific discovery through the delivery and application of DNA to every human.
Athletigen Technologies Inc.,
211 Horseshoe Lake Drive,
- Tendon and ligament injury risk
- Hamstring injury risk
- Shoulder dislocation
- Fracture risk and bone mineral density
- Age-related strength loss
- Post-exercise soreness and inflammation
- Post-exercise recovery time
- Soft tissue recovery
- Sleep quality
Athletigen has been chosen to participate in this year’s Sports Tank in New York City on April 11. Sports Tank aims to connect entrepreneurs with potential investors and influencers in the sports community.
Athletigen will pitch their DNA insights app, Iris, ‘Shark Tank’ style to executives in the sports industry for a chance to secure funding. Sports Tank is the only sports-specific pitch event and will help Athletigen gain exposure, potential partnerships and investors.
The Nova Scotian start-up is the only Canadian company to be selected for this year’s competition.
Congratulations and good luck to Athletigen!
CBC’s Brett Ruskin has more info here:
VIDEO: Global contest to find sports-industry startups has shortlisted Nova Scotia-based @Athletigen — the only Canadian company chosen. pic.twitter.com/26npFownaj
— Brett Ruskin (@Brett_CBC) April 11, 2017
HALIFAX, Nova Scotia – February 14, 2017 — Kinduct Technologies, a data and analytics software provider, and Athletigen Technologies Inc., a leader in proprietary human performance insights and genetic analytics provider, today announced that Kinduct’s software platform will soon incorporate Athletigen’s genetic insights.
“The partnership with Kinduct is an exciting opportunity, with both companies focused on pushing the limits of human performance, ” says Athletigen CEO, Dr. Jeremy Koenig. “Clients will now have access to genetic markers combined with performance data, biometric scores and subjective inputs to provide a comprehensive view of the athlete to help understand and improve their in-game performance.”
Athletigen’s proprietary platform analyzes an athlete’s DNA to empower coaches and athletes with actionable insights to inform peak performance in training and competition. The Kinduct platform enables organizations to analyze athlete data collected from different sources and then use those insights to inform decisions and drive continuous improvement in human performance.
Koenig added, “Each athlete is made for greatness, and we are one step in the journey to harnessing their maximum potential.”
“Athletigen analyses genetic markers that help athletes understand where their performance strengths and weaknesses truly lie,” says Dr. Travis McDonough, Kinduct Founder and CEO. “The partnership with Athletigen and the integration of their genetic insights into Kinduct’s platform will create a powerful tool for assessing an athlete’s condition and defining the optimal training and recovery programs.”
Kinduct’s technology platform, currently used by teams in the NHL, MLB, NFL, NBA, MLS, and NCAA allows for a two-way information exchange between coaches and athletes. Their Athlete Management System (AMS) gives teams the ability to collect, analyze, and act upon a wide range of player performance data and content such as training results, sleep schedules, maximum acceleration, deceleration, and heart rate. All of the information captured or calculated within the Kinduct platform supports informed decisions on personalized training and injury recovery programs for every athlete. This new partnership with Athletigen adds genetics as an important new layer of data.
“We see this combination of performance data and genetics as an important step in maximising player performance while reducing injury risk,” says McDonough. “Our clients can gain access to each athlete’s genetic foundation to better explain the data we capture.”
Athletigen is a leader in proprietary human performance insights and genetic analytics. In 2016, Athletigen launched Iris™, the first of its kind, a personalized performance genomics app suite that merges an athlete’s genetic predispositions with daily monitoring data, empowering coaches and athletes with actionable insights. The evolution of our product is driven by intense user research conducted with world class, Olympic and Paralympic athletes. Through genomic innovation with strategic partners, Athletigen works to deliver the most advanced research findings in human performance to its customers.
Kinduct is a leading data and analytics software provider. Kinduct’s highly secure, cloud-based platform allows human performance and sports organizations to spend less time managing their data and more time using it to inform decisions, promote constant improvement and produce exceptional results. Kinduct’s Athlete Management System is integrated with the best and brightest companies in the wearables, assessment and data collection sector. Kinduct is the software provider of choice for many professional and elite level sport organizations in the NFL, NBA, MLB, NHL, MLS and other professional or elite leagues. Kinduct’s investors include Intel Capital, CFFI Ventures Inc., and Elysian Park Ventures.
See original release here
HALIFAX, Nova Scotia–(BUSINESS WIRE)–Athletigen Technologies unveiled today the closed release of Iris™, powered by proprietary human performance insights gleaned from their partnerships with world class athletes and performance experts. Iris™ is the first of its kind personalized performance genomics app suite, which merges an athlete’s genetic predispositions with daily monitoring data, empowering coaches and athletes with actionable insights to inform peak performance in training and competition.
Built specifically for high performance athletes, Iris™ sits at the intersection of nature and nurture; where an athlete’s genetic traits interface with their environment. After analyzing an athlete’s DNA through a saliva sample, Athletigen reports on genetic markers related to nutrition, recovery and injury protection that can affect training adaptation and performance. Combining genetic insights with daily athlete monitoring of sleep, hunger, mood, training load and more, athletes and coaches are provided a holistic view of human performance data.
“Genetics is one very important piece of the human performance puzzle,” explains Dr. Jeremy Koenig, Founder & CEO of Athletigen. “We built Iris to empower athletes to understand how their performance training can be augmented through an understanding of their genetic foundation especially when considered in combination with variables that coaches have considered for more than half a century.”
Consisting of the Iris™ Athlete app and Iris™ Coach app, the software suite was built working closely with Olympic athletes and coaches at the ALTIS training center in Phoenix, AZ leading up to the Rio 2016 games. Starting this fall, ALTIS athletes & coaches will be using Iris™ as Athletigen’s official partner and pioneer of human performance research.
“Athletigen have taken the hard science behind genetics and its role in athletic performance, meticulously sifted through the noise and wealth of research available to create a product that gives coaches and other practitioners accurate and valuable information about the individuals they work with,” says Mike Boykin, Program Manager & Sprints Coach at ALTIS. “Athletigen uniquely understands that their insight does not replace the information already available, but instead serves to paint a broader picture of each athlete’s gifts and opportunities. At ALTIS, we have not only applied the genetic information to make more informed decisions about an athlete’s, macro, meso, and micro structure of training, but also plan on using their daily monitoring app to better track and make adjustments to the acute and chronic loads we place upon each athlete.”
Athletigen is a company driven by science and committed to helping athletes achieve their performance goals. Through genomic innovation with strategic partners, Athletigen works to deliver the most advanced research findings in human performance to its customers.
Iris™ is available to select high performance organizations, with the expected release to the general public next year. For more information, visit www.athletigen.com.
About Athletigen Technologies Inc.
At Athletigen, we believe that the more remarkable the athlete, the more unique they are. Our mission is to help them honor their individual training requirements necessary for world class performance. The evolution of our product is driven by intense user research conducted with world class and Olympic athletes, as well as the professionals who train them. As are result, we give high-performers the chance to celebrate their differences and truly nurture their nature.